National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 08/01/2008



General Information About Chronic Lymphocytic Leukemia






Stages of Chronic Lymphocytic Leukemia






Refractory Chronic Lymphocytic Leukemia






Treatment Option Overview







Treatment Options by Stage






Treatment Options for Refractory Chronic Lymphocytic Leukemia






To Learn More About Chronic Lymphocytic Leukemia






Get More Information From NCI






Changes to This Summary (08/01/2008)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Treatment Options by Stage

Stage 0 Chronic Lymphocytic Leukemia
Stage I, Stage II, Stage III, and Stage IV Chronic Lymphocytic Leukemia

A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.

Stage 0 Chronic Lymphocytic Leukemia

Treatment of stage 0 chronic lymphocytic leukemia is usually watchful waiting.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage 0 chronic lymphocytic leukemia.

Stage I, Stage II, Stage III, and Stage IV Chronic Lymphocytic Leukemia

Treatment of stage I, stage II, stage III, and stage IV chronic lymphocytic leukemia may include the following:

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I chronic lymphocytic leukemia, stage II chronic lymphocytic leukemia, stage III chronic lymphocytic leukemia and stage IV chronic lymphocytic leukemia.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov